Stocks to buy

Companies rushed to have their employees work from home as governments imposed locked downs. This led to a goldrush in stay-at-home investments, particularly for technology firms. Software companies that enabled virtual meetings and remote working flourished while other sectors floundered. Now that countries in the developed world have rolled out vaccinations, investors should consider hot
While the pandemic meant a setback for a number of sectors, digitalization grew apace — increasing the need for software and cloud services. In turn, the demand for cloud computing industry should grow further as more businesses adapt to work-from-home. And thus, software and cloud stocks should be hot options for investors. Overall, shares of
Investing in the biotechnology sector doesn’t have to be fraught with excessive risk. A case in point would be CRISPR Therapeutics (NASDAQ:CRSP), as CRSP stock offers outstanding value in a market that’s often overpriced. CRISPR’s mission is “Creating transformative gene-based medicines for serious diseases.” The company’s pipeline of therapeutic candidates address serious conditions such as sickle-cell
Solar energy has become a hot investment theme. Companies in the alternative energy industry are currently on a mission to help the global economy shift away from fossil fuels toward solar energy. This transition is expected to take many years as well as trillions of dollars, creating a compelling opportunity for long-term investors. Therefore, we
Novavax (NASDAQ:NVAX) transitioned from being an research and development biotech company to a Covid-19 vaccine manufacturer this month. However, NVAX stock has sold off despite several breakthroughs in its recent earnings call. Source: Ascannio/Shutterstock.com Investors seem fixated with potential FDA approval delays and poor public relations management, which negatively impacted the company stock. However, Novavax